GI endoscopy is a high-volume, durable device market on a capital-plus-consumables model. The major companies, Olympus in scopes, Boston Scientific and Medtronic in devices, and the career.

The short version
- GI endoscopy is a high-volume device market driven by procedures like colonoscopy, on a capital-plus-consumables model.
- Olympus dominates scopes and towers, with Fujifilm, Pentax, and single-use pioneer Ambu also in endoscopes.
- Boston Scientific and Medtronic lead therapeutic GI devices, with Cook Medical and CONMED also in the space.
- The sale splits into strategic capital (scopes, towers) and steady, procedure-driven single-use device pull-through.
- Enormous, demographically durable procedure volume and recurring device revenue make GI a resilient specialty.
Gastrointestinal endoscopy is one of the highest-volume areas in medicine, driven by procedures like colonoscopy for colon cancer screening and a wide range of diagnostic and therapeutic scoping. That volume, plus a business model where capital equipment pulls through a steady stream of single-use devices, makes GI a large and durable device market.
It is a specialty split between the companies that make the scopes and the companies that make the devices used through them. Here is the landscape, the major players, and what the selling is like.
01What is GI and endoscopy device sales?
It is the business of selling the equipment and devices used to see inside and treat the gastrointestinal tract. There are two broad sides. Capital endoscopy: the flexible scopes, video towers, and processors that gastroenterologists use to perform procedures. And GI devices: the single-use tools passed through those scopes, such as stents, hemostasis and resection devices, biopsy and retrieval tools, and ablation systems.
The customers are gastroenterologists and the GI labs, ambulatory endoscopy centers, and hospitals where procedures happen. Because a huge number of procedures run through these labs, the specialty combines big capital placements with high recurring consumable demand.
02Who are the major GI and endoscopy companies?
On the scope side, Olympus is the dominant force, long the leader in flexible GI endoscopes, towers, and processors. Fujifilm and Pentax (Hoya) are the other major endoscope makers, and Ambu has grown by pioneering single-use endoscopes.
On the device side, Boston Scientific is a leader in therapeutic GI devices, from stents and hemostasis to resection tools, and Medtronic is a major GI player known for technologies like its GI Genius AI-assisted polyp detection and Barrett's esophagus ablation. Cook Medical and CONMED round out the therapeutic device landscape. A GI rep typically competes on one of these two sides, scopes or devices.
03What is the GI sale like?
It is a classic capital-plus-consumables business, which shapes the whole job. Selling scopes and towers is a larger, more strategic capital sale into a lab or health system, while the single-use devices used in every procedure drive steady, recurring revenue. Reps on the device side live on procedural pull-through; reps on the capital side run longer, more consultative deals.
AI and single-use technology are reshaping the space, from computer-aided polyp detection to disposable scopes that address infection-control concerns, so reps increasingly sell newer technology and its clinical and economic case. Across both sides, procedural support and relationships with a busy GI lab are central to winning and keeping the business.
04Why is GI a strong specialty to sell in?
Because the procedure volume is enormous and durable. Colon cancer screening alone drives a massive, recurring stream of colonoscopies, and demand is demographic rather than trend-driven, so the market is resilient. The capital-plus-consumables model means a placed scope tower or a won lab keeps generating device revenue, which rewards reps who build and hold accounts.
It is also a specialty with real technology momentum. AI-assisted detection, advanced therapeutic devices, and single-use innovation keep the field evolving, so reps have new stories to tell. For someone who likes high procedure volume and a recurring-revenue model, GI is one of the more dependable device specialties.
05How do you choose a GI company?
Decide which side of the business fits you. If you like big, strategic capital sales, an endoscope and tower maker is the path; if you prefer steady, relationship- and procedure-driven selling, a therapeutic-device company suits better. The two run on different rhythms and comp dynamics.
Then weigh the territory, the company's technology story, and its standing in GI labs. The specialty rewards reps who become a trusted, useful presence in a busy lab, so pick the side and the company whose products and pace match how you like to sell, and whose technology you would be glad to learn cold.
Frequently Asked Questions
What are the top GI and endoscopy companies?
Olympus dominates flexible GI endoscopes and towers, with Fujifilm, Pentax, and single-use pioneer Ambu also making scopes. On the therapeutic device side, Boston Scientific and Medtronic lead, joined by Cook Medical and CONMED. GI reps typically compete on either the scope side or the device side.
What does a GI sales rep sell?
Either capital endoscopy, the flexible scopes, video towers, and processors used to perform procedures, or GI devices, the single-use tools passed through scopes such as stents, hemostasis and resection devices, and ablation systems. The two sides run on different sales rhythms.
Is GI a good medical sales specialty?
Yes. It is a high-volume, durable market driven by procedures like colon cancer screening colonoscopy, on a capital-plus-consumables model where won accounts generate recurring device revenue. Technology momentum from AI detection and single-use scopes keeps the field evolving.
Who do GI endoscopy reps sell to?
Gastroenterologists and the GI labs, ambulatory endoscopy centers, and hospitals where procedures are performed. Because a huge number of procedures run through these labs, procedural support and a trusted relationship with a busy lab are central to winning and keeping the business.
About This Series
This guide is part of The Lobby’s series on how the medical sales business actually works, built from company financials and market data.
Targeting GI? Set your parameters once on The Lobby and let matching roles come to you.
Gastroenterology roles on the board
See all 125 gastroenterology roles ›- Specialty Business Manager - IBD (Los Angeles/Santa Monica)Takeda · RemoteToday
- Regional Account Liaison - BioPlus Specialty Pharmacy (Oklahoma Territory)Elevance Health · Oklahoma City, Oklahoma +1Today
- Specialty Nutrition Systems, Long-Term Feeding Account Consultant - Chicago, ILAvanos Medical · IllinoisToday
